DEVELOPMENT AND MILESTONES. 5.01 Subject to the provisions of Paragraph 5.02 below, LICENSEE will, in accordance with LICENSEE's reasonable business and scientific judgement, exercise its reasonable efforts and diligence in developing VACCINE and in undertaking investigations and actions required to obtain appropriate governmental approvals to market VACCINE in at least the MAJOR MARKETS and in commercialising VACCINE in such MAJOR MARKETS. All such activity shall be undertaken at LICENSEE's expense. At LICENSEE's request and expense, LICENSOR shall supply LICENSEE with reasonable technical assistance in undertaking such investigations and actions. 5.02 The parties shall institute a development program with the objective of advancing VACCINE to commercial launch. The responsibilities of the parties shall be as follows: /*/ Confidential material omitted and filed separately with the Securities and Exchange Commission.
Appears in 1 contract
DEVELOPMENT AND MILESTONES. 5.01 Subject to the provisions of Paragraph 5.02 below, LICENSEE will, in accordance with LICENSEE's reasonable business and scientific judgement, exercise its reasonable efforts and diligence in developing VACCINE and in undertaking investigations and actions required to obtain appropriate governmental approvals to market VACCINE in at least the MAJOR MARKETS and in commercialising VACCINE in such MAJOR MARKETS. All such activity shall be undertaken at LICENSEE's expense. At LICENSEE's request and expense, LICENSOR shall supply LICENSEE with reasonable technical assistance in undertaking such investigations and actions.
5.02 The parties shall institute a development program with the objective of advancing VACCINE to commercial launch. The responsibilities of the parties shall be as follows: /*/ Confidential material omitted and filed separately with the Securities and Exchange Commission.:
Appears in 1 contract